SELLAS Life Sciences Group Inc — Cash Flow (NASDAQ:SLS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -10.42 M-26.02 M-23.81 M-31.41 M-35.4 M-28.39 M -28.39 M Cash from investing activities ——-4.5 M-5.5 M0— — Cash from financing activities 38.44 M12.07 M24.08 M22.32 M46.76 M86.3 M 86.3 M Free cash flow -10.42 M-26.02 M-23.81 M-31.41 M-35.4 M-28.39 M -28.39 M

Haberler

Solaris Resources bakır projesi ile kazanç testinde

Sellas, SLS009 hakkında preklinik verileri sunacak

SELLAS, AML Faz 2 çalışmasına ilk hastayı kaydetti

SELLAS enrolls first patient in Phase 2 AML trial of SLS009

Sellas Life Sciences, varant kullanımından 42,6 milyon dolar elde etti

Sellas Life Sciences reports $42.6 million in warrant exercise proceeds

What's Going With SELLAS Life Sciences Stock On Wednesday? - SELLAS Life Sciences Gr (NASDAQ:SLS)

H.C. Wainwright, Warintza ilerlemesi üzerine Solaris Resources hisse fiyat hedefini 16 dolara yükseltti

H.C. Wainwright raises Solaris Resources stock price target to $16 on Warintza progress

Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS)

Solaris Resources hisseleri 8,54 dolarlık 52 haftalık zirveye ulaştı

SELLAS, Avrupa SLS009 denemeleri için IMPACT-AML ile ortaklık kuruyor